Atlas Trials

Abdullah Khan

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Abdullah Khan

RecordFirmDate
Elotuzumab, CC-92480, and Dexamethasone for the Treatment of Relapsed or Refractory Myeloma After CD38- and BCMA-Targeted Therapies (NCT05981209)Abdullah Khan2023-12-21
Panobinostat in Combination With Daratumumab, Bortezomib and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma (NCT04956302)Abdullah Khan2021-09-27

Track Abdullah Khan automatically

Every clearance here is in the API, with alerts when new ones post.